☆ 4.7 Article

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

BLOOD (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)

Francesca Romana Mauro et al.

Summary: Pneumococcal vaccination response was analyzed in 112 CLL patients, with factors like age, IgG levels, prior treatment, and disease progression being associated with lower immune response rates. Age ≥ 60 years, IgG levels < 400 mg/L, prior treatment, and signs of disease progression were linked to a decreased response rate.

LEUKEMIA (2021)

添加到收藏夹

Article Hematology

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Christopher Pleyer et al.

Summary: Treatment with BTK inhibitors resulted in a lower immune response rate to the HepB-CpG vaccine, but did not significantly affect the response rate to the RZV vaccine in CLL patients.

BLOOD (2021)

添加到收藏夹

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

V. A. Simonovich et al.

Summary: There were no significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo in the treatment of severe Covid-19 pneumonia. The study results indicate that both groups had similar clinical outcomes and mortality rates after 30 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma

Clive S. Zent et al.

LEUKEMIA (2021)

添加到收藏夹

Article Medicine, General & Internal

Trends in COVID-19 Risk-Adjusted Mortality Rates

Leora Horwitz et al.

Summary: A study in a three-hospital academic health system in New York showed a decrease in hospital mortality rates among COVID-19 patients, with adjusted mortality dropping from 25.6% in March to 7.6% in August. The standardized mortality ratio also decreased from 1.26 in March to 0.38 in August, indicating an improving trend in patient outcomes. These findings suggest that mortality from COVID-19 may be decreasing even after adjusting for patient characteristics.

JOURNAL OF HOSPITAL MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020

John M. Dennis et al.

Summary: The study found a substantial improvement in survival among critically ill coronavirus disease 2019 patients in England, especially for those admitted in May and June compared to March and April. This improvement was not explained by temporal changes in patient demographics and comorbidity burden.

CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

Jesus Villar et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Hematology

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato et al.

BLOOD (2020)

添加到收藏夹

Article Oncology

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfo et al.

LEUKEMIA (2020)

添加到收藏夹

Letter Oncology

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

Lindsey E. Roeker et al.

LEUKEMIA (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients - Preliminary Report

Marcin Pasiarski et al.

PLOS ONE (2014)

添加到收藏夹

Article Geriatrics & Gerontology

A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients

Fabio Salvi et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)

添加到收藏夹

Article Oncology

Vaccination against infections in chronic lymphocytic leukemia

M Sinisalo et al.

LEUKEMIA & LYMPHOMA (2003)

添加到收藏夹

Article Hematology

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia

M Sinisalo et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)

添加到收藏夹

Article Immunology

Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia

A Hartkamp et al.

VACCINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.